GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SELVAS Healthcare Inc (XKRX:208370) » Definitions » Change In Receivables

SELVAS Healthcare (XKRX:208370) Change In Receivables : ₩-2,792 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is SELVAS Healthcare Change In Receivables?

SELVAS Healthcare's change in receivables for the quarter that ended in Mar. 2025 was ₩-1,309 Mil. It means SELVAS Healthcare's Accounts Receivable increased by ₩1,309 Mil from Dec. 2024 to Mar. 2025 .

SELVAS Healthcare's change in receivables for the fiscal year that ended in Dec. 2024 was ₩-2,841 Mil. It means SELVAS Healthcare's Accounts Receivable increased by ₩2,841 Mil from Dec. 2023 to Dec. 2024 .

SELVAS Healthcare's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩9,450 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SELVAS Healthcare's Days Sales Outstanding for the three months ended in Mar. 2025 was 119.49.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SELVAS Healthcare's liquidation value for the three months ended in Mar. 2025 was ₩26,584 Mil.


SELVAS Healthcare Change In Receivables Historical Data

The historical data trend for SELVAS Healthcare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SELVAS Healthcare Change In Receivables Chart

SELVAS Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,402.42 -901.23 -439.32 -1,094.83 -2,841.25

SELVAS Healthcare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,358.36 -496.95 -870.15 -115.79 -1,308.68

SELVAS Healthcare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,792 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SELVAS Healthcare  (XKRX:208370) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SELVAS Healthcare's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=9450.049/7216.387*91
=119.49

2. In Ben Graham's calculation of liquidation value, SELVAS Healthcare's accounts receivable are only considered to be worth 75% of book value:

SELVAS Healthcare's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=22558.198-7186.403+0.75 * 9450.049+0.5 * 8250.045
=26,584

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SELVAS Healthcare Change In Receivables Related Terms

Thank you for viewing the detailed overview of SELVAS Healthcare's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


SELVAS Healthcare Business Description

Traded in Other Exchanges
N/A
Address
174 Gajeong-ro, Yuseong-gu, Daejeon, KOR, 34129
SELVAS Healthcare Inc is a medical device manufacturing company. It is involved in equipment mainly in body composition analyzers and full-automatic tonometers for the hospital. The company's brand products include Accuniq and HIMS.

SELVAS Healthcare Headlines

No Headlines